Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Simon Memmel, Dmitri Sisario, Caren Zöller, Vanessa Fiedler, Astrid Katzer, Robin Heiden, Nicholas Becker, Lorenz Eing, Fábio L.R. Ferreira, Heiko Zimmermann, Markus Sauer, Michael Flentje, Vladimir L. Sukhorukov, Cholpon S. Djuzenova
Published Apr 5, 2017 · Vol. 8, No. 28 · pp. 45298-45310
Jone Garay, M. Blanca Piazuelo, Lizbeth Lopez-Carrillo, Yelda A. Leal, Sumana Majumdar, Li Li, Nataly Cruz-Rodriguez, Silvia J. Serrano-Gomez, Carlos S. Busso, Barbara G. Schneider, Alberto G. Delgado, Luis E. Bravo, Angela M. Crist, Stryder M. Meadows, M. Constanza Camargo, Keith T. Wilson, Pelayo Correa, Jovanny Zabaleta
Published Apr 3, 2017 · Vol. 8, No. 29 · pp. 47076-47089
Philip Sander, Haouraa Mostafa, Ayman Soboh, Julian M. Schneider, Andrej Pala, Ann-Kathrin Baron, Barbara Moepps, C. Rainer Wirtz, Michael Georgieff, E. Marion Schneider
Published Mar 30, 2017 · Vol. 8, No. 21 · pp. 35124-35137